The regenerative capacity of muscle dramatically decreases with age because old
muscle stem cells fail to proliferate in response to tissue damage. Here we uncover key
age-specific differences underlying this proliferative decline: namely, the genetic loci
of CDK inhibitors (CDKI) p21 and p16 are more epigenetically silenced in young muscle stem
cells, as compared to old, both in quiescent cells and those responding to tissue injury.
Interestingly, phosphorylated ERK (pERK) induced in these cells by ectopic FGF-2 is found
in association with p21 and p16 promoters, and moreover, only in the old cells.
Importantly, in the old satellite cells FGF-2/pERK silences p21 epigenetically and
transcriptionally, which leads to reduced p21 protein levels and enhanced cell
proliferation. In agreement with the epigenetic silencing of the loci, young muscle stem
cells do not depend as much as old on ectopic FGF/pERK for their myogenic proliferation.
In addition, other CDKIs, such asp15INK4B and p27KIP1, become
elevated in satellite cells with age, confirming and explaining the profound regenerative
defect of old muscle. This work enhances our understanding of tissue aging, promoting
strategies for combating age-imposed tissue degeneration.